Acupressure Mat for Stress, Sleep, and Premenstrual Symptoms in Students
Acupresure mat
+ Basic mat
Supportive Care Study
Summary
Study start date: November 15, 2024
Actual date on which the first participant was enrolled.This study investigates how using an acupressure mat can affect stress levels, sleep quality, and premenstrual symptoms in students who experience premenstrual syndrome (PMS). PMS can cause a variety of physical and emotional symptoms that occur before a woman's menstrual period, often impacting daily life. By targeting students with PMS, this research aims to explore whether an acupressure mat can provide a natural and non-invasive way to alleviate these symptoms, potentially offering a new method to improve well-being and quality of life for those affected. Participants in the study will be randomly assigned to use either an acupressure mat or a plain mat. The acupressure mat is intended to be used while lying down, allowing its small, raised points to apply pressure to the body, which is believed to help relieve stress and improve sleep. Researchers will measure the severity of premenstrual symptoms, perceived stress, and sleep quality both before and after the study period to determine if there are any notable changes. The study does not specify any potential risks, as the focus is on comparing the effects of the two types of mats.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.42 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives